Bendamustine HCl

For research use only.

Catalog No.S1212 Synonyms: SDX-105 (Cytostasane) HCl

17 publications

Bendamustine HCl Chemical Structure

CAS No. 3543-75-7

Bendamustine (SDX-105, Cytostasane) HCl is a DNA-damaging agent with IC50 of 50 μM in cell-free assay.

Size Price Stock Quantity  
10mM (1mL in DMSO) EUR 412 In stock
EUR 77 In stock
EUR 97 In stock
EUR 124 In stock
EUR 206 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's Bendamustine HCl has been cited by 17 publications

6 Customer Reviews

  • Fractional Analysis of Combination Therapy of SGI-1776 With Bendamustine in B-Cell Lymphoma.

    Clin Lymphoma Myeloma Leuk 2013 13 Suppl 2, S355-62. Bendamustine HCl purchased from Selleck.

  • Inhibition of DNA Synthesis by SGI-1776 (S) and Bendamustine (B) and Their Combination in JeKo-1 Cells. JeKo-1 Cells Were Treated With Dimethyl Sulfoxide (DMSO), 5 μM or 10 m M Bendamustine, 5 μM SGI-1776, or 5 μM or 10 m M Bendamustine Combined With 5 μM SGI-1776 for 24 Hours. Cells were Then Incubated With [Methyl-3H]-Thymidine at 0.8 m Ci/mL Concentration for 45 Minutes. Radioactive Incorporation Was Then Measured by Scintillation Count, and Values Were Recorded as Disintegration per Minute per Cell and Normalized to DMSO Controls. Experiments Were Performed in Triplicate and Presented as Mean ± Standard Error of the Mean.

    Clin Lymphoma Myeloma Leuk 2013 13 Suppl 2, S355-62. Bendamustine HCl purchased from Selleck.

  • WSU-NHL, Hut-78 and Jeko-1 treated with the drugs alone or in combination for 24 h. Whole-cell lysates were subjected to Western blotting using the indicated Abs. Tubulin was used to normalize protein loading.

    Apoptosis, 2017, 22(6):827-840. Bendamustine HCl purchased from Selleck.

  • Cells were grown for 6-8 days in presence of increasing concentrations of (I) bendamustine. Relative toxicity of the drugs was determined by the WST-8 cell proliferation assay, Dashed lines with open circles or triangles indicate cell proliferation in absence of an anti-lymphoma drug. Other curves represent the cells grown in increasing concentrations (indicated by the associated number) of the tested drug. Maximal absorbance (highest number of viable cells) of cells grown without an anti-lymphoma agent in each experiment was set as 100%. Standard deviations were < 5% for all measurements.

    PLoS One, 2015, 10(8):e0135314.. Bendamustine HCl purchased from Selleck.

  • Combination treatment with bendamustine (BDM) and PCI-32765 (PCI) reduced cyclin D1 expression and phosphorylation of v-akt murine thymoma viral oncogene homolog 1 (pAKT). Jeko-1 cells were treated with bendamustine (12.5 μM) and PCI-32765 (10 μM) alone or in combination for 48 h and then protein expression was analyzed with western blotting. Total AKT and β-actin are shown as loading controls. DMSO: Dimethyl sulfoxide.

    Anticancer Res, 2015, 35(12):6679-84. Bendamustine HCl purchased from Selleck.

  • (A) Morphological changes in cells treated with or without bendamustine and/or MK615 for 24 h. May-Grünwald-Giemsa solution was used to stain cells. Magnification, ×1,000

    Oncol Lett, 2017, 14(1):792-800. Bendamustine HCl purchased from Selleck.

Purity & Quality Control

Choose Selective DNA/RNA Synthesis Inhibitors

Biological Activity

Description Bendamustine (SDX-105, Cytostasane) HCl is a DNA-damaging agent with IC50 of 50 μM in cell-free assay.
DNA synthesis [1]
(Cell-free assay)
In vitro

DNA single- and double-strand breaks caused by Bendamustine are more extensive and significantly more durable than those caused by cyclophosphamide, cisplatinum, or carmustine. Bendamustine specifically regulates, transcriptionally and posttranslationally, genes involved in apoptosis, DNA repair, and mitotic checkpoints. Bendamustine uniquely regulates DNA repair pathways in non–Hodgkin's lymphoma cells compared with other alkylators. Bendamustine inhibits mitotic checkpoints and induces mitotic catastrophe. Treatment with Bendamustine results in a 60% to 80% down-regulation of the mRNA expression of all three of these genes [polo-like kinase 1 (PLK-1), Aurora Kinase A, and cyclin B1] in SU-DHL-9 cells. Twenty-six percent of the Bendamustine-treated MCF-7/ADR cells showed micronucleation compared with only 6% in DMSO control cells. [1] Using Bendamustine alone in concentrations from 1 μg/mL to 50 μg/mL, a dose- and time-dependent manner of cytotoxicity from 30.4% to 94.8% after 48 hours could be observed. The LD50 for untreated and pretreated CLL cells is 7.3 or 4.4 μg /mL, respectively. [2] Myeloid and breast carcinoma cell lines are resistant towards Bendamustine with the exception of HL-60 cells which exhibit an intermediate sensitivity. Bendamustine is found to have a very low clastogenic effect as compared with equimolar doses of lomustine. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
human MDA-MB-231 cells NV7WVZI4WHKxbHnm[ZJifGmxbjDhd5NigQ>? Mk\lO|IhcA>? NXnjXoQ1SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNSGEuVUJvMkOxJINmdGy|IHHmeIVzKDd{IHjyd{BjgSClconzeIFtKH[rb3zleEB{fGGrbnnu[y=> NV[xdGdzOjF|N{G3PVA>

... Click to View More Cell Line Experimental Data

In vivo A single dose of Bendamustine at 25 mg/kg demonstrates significant activity in all three tumor lines (DoHH-2, Granta 519 and RAMOS). DoHH-2 is the most sensitive, with 30% ORR and a 69% inhibition in tumor growth. Growth of Granta 519 and RAMOS is also inhibited by Bendamustine (%TGI of 74% and 81%, respectively), and the effect is more durable in Granta 519 (%TGD of 124%) than for DoHH-2 or RAMOS (69% and 43%, respectively). [4]


Cell Research:[1]
- Collapse
  • Cell lines: SU-DHL-1 and SU-DHL-9 cells
  • Concentrations: 0-100 μM
  • Incubation Time: 72 hours
  • Method: SU-DHL-1 and SU-DHL-9 cells are preincubated for 30 minutes with either 6 mM methoxyamine or 50 μM O6-benzylguanine, inhibitors of Ape-1 base excision repair enzyme, or alkylguanyl transferase enzyme, respectively. The cells are then exposed to various concentrations of Bendamustine for 72 hours. Cytotoxicity is evaluated by the MTT viability assay and an IC50 is determined as the drug concentration that inhibited by 50% the viability value of the untreated control. Analyses are done.
    (Only for Reference)
Animal Research:[5]
- Collapse
  • Animal Models: C.B.-17 scid mice bearing DoHH-2, Granta 519 or C.B.-17 scid-bg mice bearing SuDHL-4, RAMOS
  • Dosages: 25 mg/kg
  • Administration: Administered via i.v.
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 78 mg/mL (197.6 mM)
Ethanol 17 mg/mL (43.06 mM)
Water 2 mg/mL (5.06 mM)
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
1% DMSO+30% polyethylene glycol+1% Tween 80
For best results, use promptly after mixing.
30 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 394.72


CAS No. 3543-75-7
Storage powder
in solvent
Synonyms SDX-105 (Cytostasane) HCl
Smiles CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT03406156 Active not recruiting Drug: Obinutuzumab|Drug: Bendamustine|Drug: Venetoclax Chronic Lymphocytic Leukemia (CLL)|Small Lymphocytic Lymphoma (SLL) AbbVie|Genentech Inc. August 10 2018 Phase 3
NCT03604679 Recruiting Drug: SyB C-0501 Advanced Solid Tumor SymBio Pharmaceuticals May 24 2018 Phase 1
NCT03492775 Recruiting Drug: Obinutuzumab|Drug: Bendamustine Indolent Non-hodgkin Lymphoma Prof. Dr. Wolfgang Hiddemann|Hoffmann-La Roche|Mundipharma Research GmbH & Co KG|Ludwig-Maximilians - University of Munich December 12 2017 Phase 3

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

DNA/RNA Synthesis Signaling Pathway Map

Related DNA/RNA Synthesis Products

Tags: buy Bendamustine HCl | Bendamustine HCl ic50 | Bendamustine HCl price | Bendamustine HCl cost | Bendamustine HCl solubility dmso | Bendamustine HCl purchase | Bendamustine HCl manufacturer | Bendamustine HCl research buy | Bendamustine HCl order | Bendamustine HCl mouse | Bendamustine HCl chemical structure | Bendamustine HCl mw | Bendamustine HCl molecular weight | Bendamustine HCl datasheet | Bendamustine HCl supplier | Bendamustine HCl in vitro | Bendamustine HCl cell line | Bendamustine HCl concentration | Bendamustine HCl nmr
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID